Table 1.
The distributions of demographical characteristics in 579 control individuals and 579 patients with prostate cancer.
| Variable | Controls (n = 579) (%) | Patients (n = 579) (%) | p-Value |
|---|---|---|---|
| Age at diagnosis (years) | |||
| ≤60 | 430 (74.3%) | 101 (17.4%) | p < 0.001 |
| >60 | 149 (25.7%) | 478 (82.6%) | |
| Mean ± S.D. | 52.31 ± 10.08 | 67.08 ± 7.42 | p < 0.001 |
| PSA at diagnosis (ng/mL) | |||
| ≤10 | 309 (53.4%) | ||
| >10 | 270 (46.6%) | ||
| Pathologic Gleason grade group | |||
| 1 + 2 + 3 | 484 (83.6%) | ||
| 4 + 5 | 95 (16.4%) | ||
| Clinical T stage | |||
| 1 + 2 | 501 (86.5%) | ||
| 3 + 4 | 78 (13.5%) | ||
| Pathologic T stage | |||
| 2 | 306 (52.8%) | ||
| 3 + 4 | 273 (47.2%) | ||
| Pathologic N stage | |||
| N0 | 530 (91.5%) | ||
| N1 | 49 (8.5%) | ||
| Seminal vesicle invasion | |||
| No | 452 (78.1%) | ||
| Yes | 127 (21.9%) | ||
| Perineural invasion | |||
| No | 155 (26.8%) | ||
| Yes | 424 (73.2%) | ||
| Lymphovascular invasion | |||
| No | 482 (83.2%) | ||
| Yes | 97 (16.8%) | ||
| D’Amico classification | |||
| Low risk | 60 (10.4%) | ||
| Intermediate risk | 220 (38.0%) | ||
| High risk | 299 (51.6%) |